Howe & Rusling Inc Novavax Inc Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $6,050 - $12,883	-50 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$112.98 - $319.93 $5,649 - $15,996	-50 Reduced 50.0%	50 $9,000
Q4 2020 Feb 08, 2021	BUY	$78.74 - $139.5 $3,936 - $6,975	50 Added 100.0%	100 $11,000
Q3 2020 Nov 06, 2020	BUY	$79.44 - $178.51 $3,972 - $8,925	50 New	50 $5,000

243

76.1M

5.06M

7.19M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $931M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.